C2ARE, created in 2009 (United States), from 126 sister brands and 17477 competing brands. The C2ARE brand is owned by Celgene, a company listed in New York. C2ARE belongs to the Drug Manufacturers business sector.
Share price brand.technical-problem
Yield (Dividend per share)
(2019-2023) Stoxx Europe 600 : +36.90 % S&P 500 NY : +84.20 %